Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized multicenter study of accelerated fractionated radiotherapy with nimorazole in head and neck squamous cell carcinoma
2012-000528-17Phase 3Completed
- Sponsor
- Department of Experimental Clinical Oncology
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of nimorazole in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by Department of Experimental Clinical Oncology. Primary endpoint: Primary tumor control. Started Jun 2012; status: completed.
02
Drugs
nimorazole
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2012-000528-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000528-17.